Zobrazeno 1 - 10
of 27
pro vyhledávání: '"GIANINA FLOCCO"'
Autor:
Nikhil Kapila, Adalberto Gonzalez, Jose Melendez Rosado, Gianina Flocco, Fayssa Salomon, Mohammad Abusaif, Ishtiaq Hussain, Molly A. Moor, Jamak Modaresi-Esfeh, Fernando J. Castro
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: There is limited data on the use of anti-TNF agents in patients with concomitant cirrhosis. The aim of this study is to assess the safety of anti-TNF agents in patients with compensated cirrhosis who used these medications for the treatme
Externí odkaz:
https://doaj.org/article/66e37beef9544cc1a687a3691bdd0045
Publikováno v:
BMJ Open, Vol 10, Iss 12 (2020)
Objective Hepatitis B reactivation (HBr) is strongly associated with rituximab therapy. Guidelines advise hepatitis B screening and use of preventive nucleoside analogue (NA) in patients at risk. In this study, we examined screening trends, post-scre
Externí odkaz:
https://doaj.org/article/2d3a9e9cca9d490eaaa78f950f9edbc4
Autor:
Mohammad Maysara Asfari, Rondell P. Graham, Daniela S. Allende, Koji Hashimoto, Gianina Flocco, Federico Aucejo, Lisa Yerian, Fadi Niyazi, Carlos Romero-Marrero, K. V. Narayanan Menon, Bijan Eghtesad, Rocio Lopez, Baraa Abduljawad, Vedha Sanghi
Publikováno v:
Virchows Archiv. 480:335-347
Sustained virological response (SVR) to the treatment of recurrent HCV in liver transplant recipients has excellent clinical outcomes; however, little is known about the effects on allograft histology. The study aimed to assess the histology of the a
Autor:
Vinay, Sundaram, Sarvanand, Patel, Kirti, Shetty, Christina C, Lindenmeyer, Robert S, Rahimi, Gianina, Flocco, Atef, Al-Attar, Constantine J, Karvellas, Suryanarayana, Challa, Harapriya, Maddur, Janice H, Jou, Michael, Kriss, Lance L, Stein, Alex H, Xiao, Ross H, Vyhmeister, Ellen W, Green, Braidie, Campbell, William, Cranford, Nadim, Mahmud, Brett E, Fortune
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 28(6)
Although liver transplantation (LT) yields survival benefit for patients with acute-on-chronic liver failure grade 3 (ACLF-3), knowledge gaps remain regarding risk factors for post-LT mortality. We retrospectively reviewed data from 10 centers in the
Publikováno v:
Chest. 162:A991
Autor:
Xaralambos Zervos, Jason M. Vanatta, Andreas Tzakis, Nikhil Kapila, K. V. Narayanan Menon, Kawtar Al Khalloufi, Gianina Flocco, Samer Ebaid, Diego Reino, Christina C. Lindenmeyer
Publikováno v:
Journal of Clinical and Translational Hepatology
Background and Aims: Hepatitis C virus (HCV)-infected organs are underutilized. We aimed to assess the safety and efficacy of direct-acting antiviral agents (DAAs) therapy in HCV viremic patients who are transplanted with a liver from a HCV viremic d
Autor:
Vinay Sundaram, Christina Lindenmeyer, Kirti Shetty, Robert Rahimi, Atef Alattar, Gianina Flocco, Brett Fortune, Cynthia Gong, Suryanarayana Challa, Haripriya Maddur, Janice Jou, Michael Kriss, Lance Stein, Ross Vyhmeister, Ellen Green, Braidie Campbell, Josh Levitsky, Constantine Karvellas
Publikováno v:
Journal of Hepatology. 77:S779
Autor:
Douglas L. Seidner, Mohamed Tausif Siddiqui, Donald F. Kirby, Miguel Salazar, Gianina Flocco, Ji Seok Park
Publikováno v:
American Journal of Gastroenterology. 116:S370-S371
Autor:
Jose Melendez Rosado, Nikhil Kapila, Jamak Modaresi-Esfeh, Fernando Castro, Molly A. Moor, Gianina Flocco, Fayssa Salomon, Mohammad Abusaif, Adalberto Gonzalez, Ishtiaq Hussain
Publikováno v:
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: There is limited data on the use of anti-TNF agents in patients with concomitant cirrhosis. The aim of this study is to assess the safety of anti-TNF agents in patients with compensated cirrhosis who used these medications for the treatme
Publikováno v:
BMJ Open
ObjectiveHepatitis B reactivation (HBr) is strongly associated with rituximab therapy. Guidelines advise hepatitis B screening and use of preventive nucleoside analogue (NA) in patients at risk. In this study, we examined screening trends, post-scree